SHORT-TERM OUTCOME OF LAPAROSCOPIC DISTAL GASTRECTOMY WITH INTRACORPOREAL ANASTOMOSIS FOR THE TREATMENT OF GASTRIC CANCER AT VIETNAM NATIONAL CANCER HOSPITAL

Pham Van Binh1, Nguyen Duc Duy1, Thai Duc An2, , Ha Hai Nam1, Tran Dai Manh1, Nguyen Tuan Anh1
1 Vietnam National Cancer Hospital
2 Department of Surgery, Hanoi Medical University

Nội dung chính của bài viết

Tóm tắt

Objectives: To describe the clinical, paraclinical characteristics and the short-term results of laparoscopic distal gastrectomy with intracorporeal anastomosis for the treatment of stomach cancer. Subjects and methods: A descriptive and retrospective study on 109 patients undergoing laparoscopic distal gastrectomy with intracorporeal anastomosis at Vietnam National Cancer Hospital between January 2019 and July 2022. Results: Patients were mostly men, > 50 years old. Duration of symptom onset to hospital admission ≤ 3 months and epigastric abdominal pain were the most common symptoms. The average surgery duration was 202 minutes, 90.8% of the patients had Billroth I anastomosis (Delta shaped). Post-operative outcomes recorded very few complications, with a fast recovery time. Conclusion: Laparoscopic distal gastrectomy with intracorporeal anastomosis is a minimally invasive surgical method with a safe early result and fast post-operative recovery time.

Chi tiết bài viết

Tài liệu tham khảo

1. Nguyen Tien Binh, Pham Van Binh (2021). Evaluation of lymph node metastasis of gastric cancer pT1, pT2 stage at National Cancer Hospital. Thesis of Master, Hanoi Medical University.
2. Wang Z., Xing J., Cai J., et al. (2019). Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: A multi-center randomized controlled trial. Surgical Endoscopy; 33: 33-45.
3. Chen Y., Jia Y., Peng Z., Wang G. (2022). The prognostic role of tumor size in stage T1 gastric cancer. World Journal of Surgical Oncology; 20(1): 1-8.
4. Zhao L-Y, Zhang W-H, Chen X-Z, et al. (2015). Prognostic significance of tumor size in 2,405 patients with gastric cancer: A retrospective cohort study. Medicine; 94(50).
5. Japanese Gastric Cancer Association jgca@ koto. kpu-m. ac. jp. (2022). Japanese gastric cancer treatment guidelines 2021. Gastric Cancer; 1-25.
6. Lordick F., Carneiro F., Cascinu S., et al. (2022). Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Annals of Oncology; 33(10): 1005-1020.
7. Kim H-G, Park J-H, Jeong S-H, et al. (2013). Totally laparoscopic distal gastrectomy after learning curve completion: Comparison with laparoscopy-assisted distal gastrectomy. Journal of Gastric Cancer; 13(1): 26-33.
8. Chen K., Xu X., Mou Y., et al. (2013). Totally laparoscopic distal gastrectomy with D2 lymphadenectomy and Billroth II gastrojejunostomy for gastric cancer: Short-and medium-term results of 139 consecutive cases from a single institution. International Journal of Medical Sciences; 10(11): 1462-1470.
9. Chen B., Xiong D., Pan Z., et al. (2018). Totally laparoscopic verse laparoscopic assisted distal gastrostomy for gastric cancer: An update meta-analysis. Oncotarget; 9(15): 12333.
10. Hamashima C (2016). Benefits and harms of endoscopic screening for gastric cancer. World Journal of Gastroenterology; 22(28), 6385.